Since the advent of SARS-CoV-2 in Dec. 2019, the global endeavor
to identify the pathogenic mechanism of COVID-19
has been ongoing. Although humoral immunity including
neutralizing activity play an important role in protection from
the viral pathogen, dysregulated antibody responses may be
associated with the pathogenic progression of COVID-19,
especially in high-risk individuals. In addition, SARS-CoV-2
spike-specific antibodies acquired by prior infection or vaccination
act as immune pressure, driving continuous population
turnover by selecting for antibody-escaping mutations.
Here, we review accumulating knowledge on the potential
role of humoral immune responses in COVID-19, primarily
focusing on their beneficial and pathogenic properties. Understanding
the multifaceted regulatory mechanisms of humoral
responses during SARS-CoV-2 infection can help us to develop
more effective therapeutics, as well as protective measures
against the ongoing pandemic.
Citations
Citations to this article as recorded by
Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic So-Hee Kim, Yuri Kim, Sangeun Jeon, Uni Park, Ju-Il Kang, Kyeongseok Jeon, Hye-Ran Kim, Songhyeok Oh, Ji-Young Rhee, Jae-Phil Choi, Wan Beom Park, Sang Won Park, Jeong-Sun Yang, Joo-Yeon Lee, Jihye Kang, Hyoung-Shik Shin, Yeonjae Kim, Seungtaek Kim, Yeon- Science Advances.2024;[Epub] CrossRef
Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant Tae-Hun Kim, Sojung Bae, Sunggeun Goo, Jinjong Myoung Journal of Microbiology and Biotechnology.2023; 33(12): 1587. CrossRef
Two years of COVID-19 pandemic: where are we now? Jinjong Myoung Journal of Microbiology.2022; 60(3): 235. CrossRef